Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
This clinical trial update summarizes a completed health technology assessment evaluating diagnostic approaches for Alzheimer's disease.
-
CLINICAL_TRIALS withdrawal · 2015-05-27Clinical Trial Update: Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients [Phase 4]
This report indicates that the Phase 4 trial evaluating safety and efficacy of divalproex in combination with quetiapine for elderly patient…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Olfactory Neuroepithelial Tissue of Alzheimer Disease
A completed clinical trial investigating olfactory neuroepithelium in individuals with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease [NA]
Clinical trial update indicating the completion of NCT01126099 evaluating prazosin for disruptive agitation in Alzheimer's disease. Results …
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Sound Estimation and Accuracy Task [NA]
The Sound Estimation and Accuracy Task trial (NCT02271685) sponsored by Carnegie Mellon University has completed and involves Parkinson's di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-05-19FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (florbetaben F-18) from Lantheus Biosciences Ltd., updating labeling to support its use…
-
FDA approval · 2015-05-18FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (FLORBETABEN F 18) submitted by Lantheus Biosciences Ltd.
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles [NA]
This clinical trial update investigates brain changes associated with rivastigmine in Alzheimer's disease, stratified by butyrylcholinestera…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Project ACT: Advancing Caregiving Techniques [Phase 3]
Phase 3 clinical trial evaluating Project ACT, a caregiving techniques program for Alzheimer's disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease [Phase 2]
Phase 2 long-term follow-up study in Alzheimer's disease completed; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) [Phase 3]
A Phase 3 randomized, double-blind study comparing two titration methods of the rivastigmine transdermal patch in Alzheimer's disease patien…
-
FDA label_change · 2015-05-04FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (Florbetaben F-18) by Lantheus Biosciences Ltd., expanding its labeling.
-
FDA approval · 2015-05-01FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Torrent Pharmaceuticals Limited.
-
FDA approval · 2015-05-01FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Biomedical Research Foundation of Northwest Louisiana)
FDA approved Fluorodeoxyglucose F-18 as a diagnostic radiopharmaceutical for positron emission tomography (PET) imaging under an original ap…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating a dietary supplement version of Anatabloc for Alzheimer's disease has been terminated. The trial was sponsored by…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Online Caregiver Psychoeducation and Support for Alzheimer's [Phase 2, Phase 3]
This document reports the completion and results posting of a Phase 2/3 clinical trial sponsored by the US Department of Veterans Affairs ev…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease [NA]
This update indicates a completed clinical trial evaluating sensory support care for elderly patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements
Completed clinical trial evaluating Cerefolin and CerefolinNAC on biomarker measurements in people with mild cognitive impairment and Alzhei…
-
FDA approval · 2015-04-23FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic donepezil hydrochloride product from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment [Phase 1]
A Phase 1 pharmacokinetics and pharmacodynamics study of POSIPHEN in subjects with amnestic mild cognitive impairment and Alzheimer's diseas…
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: QTc Study of Rosi XR in Healthy Volunteers [Phase 1]
A Phase 1 QTc study of the drug Rosi XR in healthy volunteers has been withdrawn by the sponsor, GlaxoSmithKline.
-
FDA approval · 2015-04-10FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the original ANDA for memantine hydrochloride as a generic product.
-
FDA approval · 2015-04-10FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for memantine hydrochloride, a generic version of memantine.
-
CLINICAL_TRIALS trial_result · 2015-04-09Clinical Trial Update: Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development [Phase 1]
An early-phase clinical trial evaluating cognitive properties of new drug candidates for Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Pain Management and Behavioral Outcomes in Patients With Dementia [Phase 2]
Phase 2 clinical trial update from the US Department of Veterans Affairs assessing pain management and behavioral outcomes in dementia patie…